Mr. Jim Breslin:

We went into 2018 with a certain view of the screening programme, a policy objective to introduce the HPV test, a funding agreement for how we would do it and so on, but the world changed during the course of April and May 2018. What Mr. McCallion outlined has whole layers to it in terms of the capacity of the programme, the personnel within it, the multiple challenges they were facing daily and weekly, the need to solidify the programme and recruit under it to bring in new expertise and new personnel and put new processes in place. All of this undoubtedly has had implications for what this time last year would have been a steady state, go forward approach to move the programme from one test to another.